awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33334489-E02D4114-9BDF-486E-A380-BE245109A92F
Q33334489-E02D4114-9BDF-486E-A380-BE245109A92F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33334489-E02D4114-9BDF-486E-A380-BE245109A92F
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.
P2860
Q33334489-E02D4114-9BDF-486E-A380-BE245109A92F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33334489-E02D4114-9BDF-486E-A380-BE245109A92F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d1f2531c8d1e4ddbee97e79f82d49b90ac148a25
P2860
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.